On Feb. 18, CHA testified at the Board of Pharmacy Enforcement and Compounding Committee about member concerns on recent specialty pharmacy payer changes. These policy changes disrupt the traditional buy-and-bill method, where hospitals buy and store specialty drugs for general use and bill payers for the dose used when administered to the patient.
This content is restricted to members.
